Mirae Asset Global Investments

Mirae Asset Global Investments is one of Asia’s largest independent financial groups and a leading global asset manager. Founded in 1997 in South Korea, the firm manages over $256 billion in assets across public and private markets worldwide as of December 2024[1][2][3]. Its services include active and passive investment management across equities, fixed income, real estate, venture capital/growth equity investments, ETFs, and alternative assets[1][2]. While not itself a biotech or pharma company nor directly developing drugs or medical products, the group invests significantly in healthcare through sector funds and via its U.S.-based affiliate "Mirae Asset Capital Life Science," which focuses on venture investments in biotechnology companies[6][7][10].